HK1072597A1 - Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same - Google Patents

Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same

Info

Publication number
HK1072597A1
HK1072597A1 HK05105174.2A HK05105174A HK1072597A1 HK 1072597 A1 HK1072597 A1 HK 1072597A1 HK 05105174 A HK05105174 A HK 05105174A HK 1072597 A1 HK1072597 A1 HK 1072597A1
Authority
HK
Hong Kong
Prior art keywords
phenyltetrahydroisoquinolines
medicaments
substituted
production
addition
Prior art date
Application number
HK05105174.2A
Inventor
Armin Hofmeister
Uwe Heinelt
Hans-Jochen Lang
Markus Bleich
Klaus Wirth
Michael Gekle
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1072597A1 publication Critical patent/HK1072597A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
HK05105174.2A 2001-12-05 2005-06-22 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same HK1072597A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10159714 2001-12-05
PCT/EP2002/012990 WO2003048129A1 (en) 2001-12-05 2002-11-20 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same

Publications (1)

Publication Number Publication Date
HK1072597A1 true HK1072597A1 (en) 2005-09-02

Family

ID=7708117

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05105174.2A HK1072597A1 (en) 2001-12-05 2005-06-22 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same

Country Status (34)

Country Link
EP (1) EP1453810B1 (en)
JP (1) JP4510457B2 (en)
KR (1) KR20050044724A (en)
CN (1) CN100497314C (en)
AR (1) AR037620A1 (en)
AT (1) ATE425968T1 (en)
AU (1) AU2002356689B2 (en)
BR (1) BR0214753A (en)
CA (1) CA2469385A1 (en)
CO (1) CO5580748A2 (en)
DE (1) DE50213372D1 (en)
DK (1) DK1453810T3 (en)
EC (1) ECSP045138A (en)
ES (1) ES2324528T3 (en)
HK (1) HK1072597A1 (en)
HR (1) HRP20040507A2 (en)
HU (1) HUP0600854A2 (en)
IL (1) IL162316A0 (en)
MA (1) MA27147A1 (en)
MX (1) MXPA04005343A (en)
MY (1) MY157371A (en)
NO (1) NO326650B1 (en)
NZ (1) NZ533322A (en)
OA (1) OA12740A (en)
PE (1) PE20030726A1 (en)
PL (1) PL369313A1 (en)
PT (1) PT1453810E (en)
RS (1) RS48004A (en)
RU (1) RU2298003C2 (en)
TN (1) TNSN04100A1 (en)
TW (1) TWI281860B (en)
UA (1) UA77042C2 (en)
WO (1) WO2003048129A1 (en)
ZA (1) ZA200403711B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312963A1 (en) * 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
DE102004046492A1 (en) 2004-09-23 2006-03-30 Sanofi-Aventis Deutschland Gmbh Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
US20060111393A1 (en) * 2004-11-22 2006-05-25 Molino Bruce F 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
DE102005001411A1 (en) * 2005-01-12 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
NZ561613A (en) 2005-02-18 2010-12-24 Astrazeneca Ab Antibacterial piperidine derivatives
WO2006092599A2 (en) * 2005-03-04 2006-09-08 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
DE102005044817A1 (en) * 2005-09-20 2007-03-22 Sanofi-Aventis Deutschland Gmbh Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
DE102006012545A1 (en) 2006-03-18 2007-09-27 Sanofi-Aventis Substituted 2-amino-4-phenyl-dihydroquinolines, process for their preparation, their use as medicament, and medicament containing them
AU2009334511C1 (en) * 2008-12-31 2016-08-18 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en) * 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10543207B2 (en) 2008-12-31 2020-01-28 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ES2446971T3 (en) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahydroisoquinolines substituted with aryl, heteroaryl, and heterocycle and their use
AU2013304813B2 (en) * 2012-08-21 2016-08-04 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2014250956B2 (en) 2013-04-12 2019-04-04 Ardelyx, Inc. NHE3-binding compounds and methods for inhibiting phosphate transport
CN103788084A (en) * 2014-03-02 2014-05-14 湖南华腾制药有限公司 Tetrahydroisoquinoline derivative and synthesis method thereof
ES2701498T3 (en) 2014-07-25 2019-02-22 Taisho Pharmaceutical Co Ltd Phenyltetrahydroisoquinoline compound substituted with heteroaryl
JP6903923B2 (en) * 2016-01-22 2021-07-14 大正製薬株式会社 A drug containing a phenyltetrahydroisoquinoline compound substituted with a heteroaryl as an active ingredient.
EP3565808A1 (en) 2017-01-09 2019-11-13 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
CA3049679A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Inhibitors of nhe-mediated antiport
CN114702478B (en) * 2020-12-18 2024-01-05 上海济煜医药科技有限公司 Benzo-heterocycle substituted tetrahydroisoquinoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951702A1 (en) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Use of 2-amino-3,4-dihydroquinazolines for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions
CN100436420C (en) * 1999-11-03 2008-11-26 Amr科技公司 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
DE60038185T2 (en) * 1999-11-03 2009-02-19 Amr Technology, Inc. ARLY AND HETEROARYL SUBSTITUTED TETRAHYDROISOQUINOLINES AND THEIR USE AS INHIBITORS OF THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE
EP1113007A1 (en) * 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
DE10019062A1 (en) * 2000-04-18 2001-10-25 Merck Patent Gmbh Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia

Also Published As

Publication number Publication date
EP1453810A1 (en) 2004-09-08
ES2324528T3 (en) 2009-08-10
MY157371A (en) 2016-06-15
TNSN04100A1 (en) 2006-06-01
JP2005515205A (en) 2005-05-26
EP1453810B1 (en) 2009-03-18
JP4510457B2 (en) 2010-07-21
CA2469385A1 (en) 2003-06-12
DK1453810T3 (en) 2009-07-20
NO20042158L (en) 2004-08-27
IL162316A0 (en) 2005-11-20
OA12740A (en) 2006-06-30
PL369313A1 (en) 2005-04-18
CN100497314C (en) 2009-06-10
ECSP045138A (en) 2004-08-27
TW200306190A (en) 2003-11-16
TWI281860B (en) 2007-06-01
WO2003048129A1 (en) 2003-06-12
RS48004A (en) 2006-10-27
ATE425968T1 (en) 2009-04-15
UA77042C2 (en) 2006-10-16
CN1617856A (en) 2005-05-18
AR037620A1 (en) 2004-11-17
RU2004120295A (en) 2006-01-10
RU2298003C2 (en) 2007-04-27
NZ533322A (en) 2006-02-24
PE20030726A1 (en) 2003-09-30
AU2002356689A1 (en) 2003-06-17
DE50213372D1 (en) 2009-04-30
MA27147A1 (en) 2005-01-03
NO326650B1 (en) 2009-01-26
CO5580748A2 (en) 2005-11-30
BR0214753A (en) 2004-12-14
HUP0600854A2 (en) 2007-02-28
KR20050044724A (en) 2005-05-12
MXPA04005343A (en) 2004-09-27
ZA200403711B (en) 2005-06-09
AU2002356689B2 (en) 2008-05-15
HRP20040507A2 (en) 2005-08-31
PT1453810E (en) 2009-05-27

Similar Documents

Publication Publication Date Title
HK1072597A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
IL160440A0 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
PL378065A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
HK1077818A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
HK1056715A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
MXPA03002309A (en) Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds.
HK1123806A1 (en) Xanthine derivative, production and use thereof as a medicament
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
HK1069820A1 (en) Benzoxazinone-derived compounds, their preparation und use as medicaments
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
IL175127A0 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
HUP0204360A3 (en) Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament and medicaments containing said compounds
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
SI1427730T1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2002329270A1 (en) Salicylic acid salts, methods for the production and use thereof as medicaments
SI1294682T1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
SI1560826T1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
HU0001178D0 (en) New propene-carbon acid-amidoxim derivatives, process for their production and medicaments containing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131120